During the corresponding time, Igm Biosciences Inc recorded a revenue increase by 11353.19 % year on year, While revenue at the Igm Biosciences Inc 's corporate clients
Igm Biosciences Inc's Comment on Sales, Marketing and Customers
The company provides products to customers who bill federal programs, including healthcare providers, healthcare clearinghouses, health plans, and business associates handling individually identifiable health information. Its products are influenced by coverage and reimbursement decisions from third-party payors, including federal, state, and foreign government healthcare programs, commercial insurers, and managed healthcare organizations. The company serves specific market segments such as physicians (including doctors of medicine and osteopathy, dentists, podiatrists, optometrists, and licensed chiropractors), certain non-physician healthcare professionals (physician assistants and nurse practitioners), and teaching hospitals. Compliance with regulations such as HIPAA, HITECH, and the Physician Payments Sunshine Act is required in its interactions with these customers and markets.
Igm Biosciences Inc’s Comment on Sales, Marketing and Customers
The company provides products to customers who bill federal programs, including healthcare providers, healthcare clearinghouses, health plans, and business associates handling individually identifiable health information. Its products are influenced by coverage and reimbursement decisions from third-party payors, including federal, state, and foreign government healthcare programs, commercial insurers, and managed healthcare organizations. The company serves specific market segments such as physicians (including doctors of medicine and osteopathy, dentists, podiatrists, optometrists, and licensed chiropractors), certain non-physician healthcare professionals (physician assistants and nurse practitioners), and teaching hospitals. Compliance with regulations such as HIPAA, HITECH, and the Physician Payments Sunshine Act is required in its interactions with these customers and markets.
Sources:
Igm Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Igm Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Igm Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
